We are live on
!
Find out more
Immunic
IMUX
IMUX
61 hedge funds and large institutions have $92.4M invested in Immunic in 2024 Q3 according to their latest regulatory filings, with 12 funds opening new positions, 17 increasing their positions, 14 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
140% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 5
49% more capital invested
Capital invested by funds: $62.1M → $92.4M (+$30.3M)
21% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 14
11% more funds holding
Funds holding: 55 → 61 (+6)
0.02% more ownership
Funds ownership: 6.2% → 6.22% (+0.02%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
83% less call options, than puts
Call options by funds: $118K | Put options by funds: $698K
Holders
61
Holders Change
+6
Holders Change %
+10.91%
% of All Funds
0.88%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.01%
New
12
Increased
17
Reduced
14
Closed
5
Calls
$118K
Puts
$698K
Net Calls
-$580K
Net Calls Change
-$221K
Top Buyers
| 1 |
Focus Partners Wealth
Boston,
Massachusetts
|
+$3.05M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.37M |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$738K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$607K |
| 5 |
Morgan Stanley
New York
|
+$520K |
